TNBC is one of the most malignant and aggressive breast cancer subtypes, characterized by the absence of ER, PR, and HER2, and it exhibits a higher rate of recurrence and mortality compared to other subtypes (Bianchini et al., 2016). This evidence concerns the gene ESR1 and breast cancer.